{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:11:24Z","timestamp":1698970284431},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":9828,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[1981,8]]},"abstract":"<jats:sec><jats:label \/><jats:p><jats:bold>Summary: <\/jats:bold> Mice were injected with intracerebroventricular (i.c.v.) kainic acid (KA; 0.1\/\u03bcg per animal) and the pentetrazol test was carried out on the fifth day after the administration of the amino acid. The following antiepileptic drugs were tested for anticonvulsant activity in mice lesioned with KA: diazepam (0.4 mg\/kg), phenobarbital (12.5 and 25 mg\/kg), trimethadione (200 and 400 mg\/kg), depakine (200 and 400 mg\/kg), carbamazepine (10 and 20 mg\/kg), lefadol (bromophenylsuccinimide; 20 mg\/kg), and acetazolamide (320 mg\/kg). All drugs were given intraperitoneally, except for carbamazepine, which was also given orally in doses of 100 and 200 mg\/kg. Pentetrazol was administered subcutaneously in a dose of 110 mg\/kg, and the animals were subsequently observed for the occurrence of clonic and tonic convulsions within 30 min. The protective effects of diazepam and phenobarbital were significantly reduced in the KA\u2010lesioned animals, while the actions of the remaining anticonvulsants were unaltered. Moreover, a substantial loss of pyramidal cells in the CA 3 field of the hippocampus was noted after i.c.v. injection of KA. It may therefore be concluded that the mechanism of the action of diazepam and phenobarbital are partially dependent on the intact functions of the hippocampal formation.<\/jats:p><\/jats:sec><jats:sec><jats:title>R\u00c9SUM\u00c9<\/jats:title><jats:p>Des souris re\u00e7oivent une injection intra\u2010ventriculaire de 0.1 \u03bcg d'acide ka\u00efnique (AK) et re\u00e7oivent cinq jours plus tard une injection souscutan\u00e9e de 110 mg\/kg de pentetrazol. Diff\u00e9rents m\u00e9dicaments ont \u00e9t\u00e9 utilis\u00e9s pour appr\u00e9cier leur action anti\u2010\u00e9pileptique sur ce mod\u00e8le exp\u00e9rimental: diaz\u00e9pam (0,4 mg\/kg); ph\u00e9nobarbital (12,5 et 25 mg\/kg); trimethadione (200 et 400 mg\/kg); valproate de soude (200 et 400 mg\/kg; carbamaz\u00e9pine (10 et 20 mg\/kg); bromoph\u00e9nylsuccinimide (20 mg\/kg); ac\u00e9tazolamide (320 mg\/kg). Tous ces m\u00e9dicaments ont \u00e9t\u00e9 inject\u00e9s intrap\u00e9riton\u00e9alement, a l'exception de la carbamaz\u00e9pine qui a \u00e9galement \u00e9t\u00e9 utilis\u00e9e per os \u00e0 la dose de 100 et 200 mg\/kg. L'effet protecteur du diaz\u00e9pam et du ph\u00e9nobarbital a \u00e9t\u00e9 significativement r\u00e9duit chez ces animaux tandis que Faction protectrice des autres anticonvulsivants est demeur\u00e9e intacte. Si l'on consid\u00e8re que, d'autre part, tous ces animaux ont pr\u00e9sent\u00e9 une perte substantielle des cellules pyramidales du champ CA 3 de leur hyppocampe s\u00f2us l'effet de l'AK, on arrive a la conclusion que le m\u00e9canisme de l'action anti\u2010convulsivante du diaz\u00e9pam et du ph\u00e9nobarbital d\u00e9pend partiellement du bon fonctionnement de la formation hippocampique.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESUMEN<\/jats:title><jats:p>Se inyect\u00f3\u00e1cido ka\u00ednico (KA), 0,1 \u03bcg en cada rat\u00f3n, intraventricularmente en una serie de animates y despu\u00e9s se llev\u00f3 a cabo la prueba del pentetrazol cinco d\u00edas despu\u00e9s de la administraci\u00f3n de ese amino\u00e1cido. Se estudiaron las propiedades anticomiciales de los siguientes f\u00e1rmacos en esos ratones lesionados con KA: diacepan, 0,4 mg\/kg, fenobarbital, 12,5 y 25 mg\/kg, trimetadiona, 200 y 400 mg\/kg, valproato, 200 y 400 mg\/kg, carbamacepina, 10 y 20 mg\/kg, bromofenilsuccinimida, 20 mg\/kg, y acetazolamida, 320 mg\/kg. Todos estos f\u00e1rmacos se administraron por v\u00eda intraperitoneal, excepto la carbapacepina, que tambi\u00e9n se di\u00f3 oralmente en dosis de 100 y 200 mg\/kg. El pentetrazol se administr\u00f3 subcutaneamente en una sola dosis de 110 mg\/kg y despu\u00e9s se observ\u00f3 a cada animal durante 30 minutos para ver si presentaban convulsiones t\u00f3nicas y cl\u00f3nicas. El efecto protector del diacepan y del fenobarbital disminuy\u00f3 de modo significativo en los animales lesionados con KA, mientras que la acti\u00f3n de los dem\u00e1s anticomiciales permaneci\u00f3 inalterada. Adem\u00e1s, pudo documentarse la p\u00e9rdida de c\u00e9lulas piramidales en el campo CA 3 del hipocampo despu\u00e9s de la inyecci\u00f3n intraventricular de KA. Puede concluirse, por lo tanto, que los mecanismos de acci\u00f3n del diacepan y del fenobarbital son parcialmente dependientes de la integridad funcional de la formaci\u00f3n hipocampal.<\/jats:p><\/jats:sec><jats:sec><jats:title>ZUSAMMENFASSUNG<\/jats:title><jats:p>Die Tiere erhielten intracerebroventrikul\u00e4r Kains\u00e4ure (KA 0,1 \u03bcg je Maus) injiziert. Der Pentetrazoltest wurde am 5. Tag nach der Aminos\u00e4ureninjektion durchgef\u00fchrt. Folgende antiepileptische Medikamente wurden auf ihre antikonvulsiver Aktivit\u00e4t bei M\u00e4usen mit dieser L\u00e4sion getestet: Diazepam (0,4 mg\/kg), Phenobarbital (12,5 und 25 mg\/kg), Trimethadion (200 und 400 mg\/kg), Depakine (200 und 400 mg\/kg), Carbamazepin (10 und 20 mg\/kg) und Lefadol\/Bromophenylsuccinimid (20 mg\/kg) sowie Acetazolamid (320 mg\/kg). Alle Medikamente wurden intraperitoneal verabfolgt au\u00dfer dem Carbamazepin, das auch oral in Dosen von 100 und 200 mg\/kg gegeben wurden. Pentetrazol wurde subkutan in einer Dosis von 100 mg\/kg verabfolgt. Die Tiere wurden anschlie\u00dfend innerhalb 30 Min. hinsichtlich des Auftretens klonischer und tonischer Kr\u00e4mpfe beobachtet. Der Schutzeffekt von Diazepam und Phenobarbital war bei Tieren mit KA\u2010L\u00e4sion signifikant reduziert, die Wirkung der \u00fcbrigen Antikonvulsiva blieb unbeeinflu\u00dft. Dar\u00fcberhinaus wurde der Substanzverlust an Pyramidenzellen im CA 3 Feld des Hippocampus nach intracerebroventrikul\u00e4rer Injektion von KA gezeigt. Daraus kann geschlossen werden, da\u00df die Wirkungsweise von Diazepam und Phenobarbital zum Teil von der intakten Funktion des Hippocampus abhangt.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1528-1157.1981.tb06151.x","type":"journal-article","created":{"date-parts":[[2007,11,21]],"date-time":"2007-11-21T13:23:05Z","timestamp":1195651385000},"page":"407-414","source":"Crossref","is-referenced-by-count":14,"title":["Effects of Some Antiepileptic Drugs in Pentetrazol\u2010Induced Convulsions in Mice Lesioned with Kainic Acid"],"prefix":"10.1111","volume":"22","author":[{"given":"Stanislaw J.","family":"Czuczwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lechoslaw","family":"Turski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Turski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdzislaw","family":"Kleinrok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90571-7"},{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.9.3805"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1981.tb13701.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(81)90115-5"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(74)90051-3"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6768130"},{"key":"e_1_2_1_7_1","first-page":"383","article-title":"The anticonvulsant action of inhibitors of carbonic anhydrase: Site and mode of action in rats and mice","volume":"156","author":"Gray WD","year":"1967","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1975.tb06938.x"},{"issue":"1898","key":"e_1_2_1_9_1","article-title":"n\u2010Dipropylacetate induces a preferential increase in nerve terminal GABA in vivo","author":"Iadarola MJ","year":"1979","journal-title":"Soc Neurosci Abstr"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb05250.x"},{"key":"e_1_2_1_11_1","first-page":"597","volume-title":"Anti\u2010epileptic Drugs: Mechanisms of Action","author":"Killam EK","year":"1980"},{"key":"e_1_2_1_12_1","article-title":"Biochemical consequences of kainic acid injections into the lateral ventricle in the rat","author":"Kleinrok Z.","year":"1981","journal-title":"Ada Biochim Pol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1980.tb04303.x"},{"key":"e_1_2_1_14_1","first-page":"261","article-title":"Prevention of kainic acid\u2010induced seizure\u2010like activity by antiepileptic drugs","volume":"32","author":"Kleinrok Z.","year":"1980","journal-title":"Pol J Pharmacol Pharm"},{"key":"e_1_2_1_15_1","first-page":"265","article-title":"Effect of intracerebroventricular injection of kainic acid on electrically and chemically\u2010induced convulsions in mice","volume":"32","author":"Kleinrok Z.","year":"1980","journal-title":"Pol J Pharmacol Pharm"},{"key":"e_1_2_1_16_1","first-page":"32","volume-title":"Epileptic Seizures\u2014Behaviour\u2014Pain","author":"Koella WP","year":"1976"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00498692"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/271563a0"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.4.432"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00508411"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(78)90145-4"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(73)90025-7"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.918669"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/271676a0"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(74)90640-4"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/281688a0"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00507844"},{"key":"e_1_2_1_28_1","first-page":"809","article-title":"Effects of systemic muscimol and GABA in the spinal cord and superior cervical ganglion of the cat","volume":"33","author":"Pole P.","year":"1977","journal-title":"Experientia"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00504702"},{"key":"e_1_2_1_30_1","first-page":"195","article-title":"The role of 5\u2010hydroxytryptamine in the mechanism of action of anticonvulsant drugs","volume":"27","author":"Przegali\u0144ski E.","year":"1975","journal-title":"Pol J Pharmacol Pharm (Suppl)"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(78)90161-2"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1974.tb03997.x"},{"key":"e_1_2_1_33_1","first-page":"81","article-title":"The role of central glycine receptors in the pharmacological actions of the benzodiazepines","volume":"14","author":"Snyder SH","year":"1975","journal-title":"Adv Biochem Psychopharmacol"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90976-4"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(73)90137-4"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90285-6"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1157.1981.tb06151.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1157.1981.tb06151.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T11:41:45Z","timestamp":1698925305000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1157.1981.tb06151.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,8]]}},"alternative-id":["10.1111\/j.1528-1157.1981.tb06151.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1157.1981.tb06151.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,8]]}}}